Complement 3 (C3) serum levels are considered a pro-inflammatory biomarker for insulin resistance in obesity (17), and in our study, C3 serum levels exhibited a decreasing trend overall. This evidence concerns the gene C3 and obesity due to melanocortin 4 receptor deficiency.